Frusemide Infusion for the Prevention of Deterioration in Renal Function Post Cardiac Surgery.

Frusemide Infusion for the Prevention of Deterioration of Renal Function in Post Cardiac Surgery

NCT00246675•Melbourne Health

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Renal Impairment After Cardiac Surgery

Interventions

Frusemide

Locations

Australia

Locations (1)

Intensive Care Unit, Royal Melbourne Hospital

Parkville, Victoria, Australia

Key Dates

Last Updated

April 27, 2015

Sponsors

Lead Sponsor

Melbourne Health

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 27, 2015Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions